上海微创电生理医疗科技股份有限公司关于一次性使用压力监测心脏脉冲电场消融导管获批上市的自愿披露公告

Core Points - Shanghai MicroPort EP MedTech Co., Ltd. has received approval from the National Medical Products Administration for its disposable pressure monitoring cardiac pulsed electric field ablation catheter [1] - The product utilizes strain gauge technology for pressure sensing, combined with pulsed electric field technology, magnetic positioning technology, and saline infusion technology, aimed at treating arrhythmias [1] - The approval enhances the company's portfolio of ablation energy products, which includes radiofrequency, cryoablation, and pulsed electric field technologies, thereby strengthening its competitive edge and market expansion capabilities [1] Product Details - The catheter is designed to work with cardiac pulsed electric field ablation devices and can provide real-time measurements of contact pressure between the catheter tip and the heart wall when used with a three-dimensional cardiac electrophysiology mapping system [1] - The registration certificate obtained signifies the product's qualification for market access in China, although actual sales performance post-launch will be influenced by multiple factors [2]